Total Reports
1,468
FDA CVM filings
Dog /
FDA CVM · 2025 release 1,468 reports on file
Pointing Dog - Hungarian Short-haired (Vizsla) - FDA Adverse Event Profile
Adverse-event records for Pointing Dog - Hungarian Short-haired (Vizsla) (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Pointing Dog - Hungarian Short-haired (Vizsla)'s FDA record: #89 most-reported dog breed, 1,468 total reports, 4.0% death-coded (58 reports).
- #89
- most-reported dog breed
- 4.0%
- death-coded report share
- 290
- Vomiting - top reaction
- 4.7 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
58
of 1,468 reports
Death Rate
4.0%
death-coded share
Avg Age at Report
4.7 yr
23.0 kg avg weight
Death-Coded Outcome Share
Pointing Dog - Hungarian Short-haired (Vizsla) death-coded reports 4.0%
Cross-breed median
4.0% of 1,468 pointing dog - hungarian short-haired (vizsla) reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 23.0 kg (50.7 lbs)
Top Reported Reactions
Vomiting 290
Lack of efficacy (endoparasite) - hookworm 119
Diarrhoea 110
Lethargy (see also Central nervous system depression in 'Neurological') 99
Emesis 87
Lack of efficacy (endoparasite) - heartworm 80
Digestive tract disorder NOS 78
Seizure NOS 71
Lack of efficacy - NOS 70
INEFFECTIVE, ASCARIDS NOS 48
INEFFECTIVE, HOOKS 46
Other abnormal test result NOS 43
Lack of efficacy (endoparasite) - roundworm NOS 42
Anorexia 40
Emesis (multiple) 36
Most Referenced Drugs
Milbemycin Oxime + Spinosad 237
Ivermectin + Pyrantel As Pamoate Salt 207
Afoxolaner 118
Pyrantel Pamoate;Sarolaner 92
Milbemycin Oxime + Praziquantel 81
Moxidectin 73
Fluralaner Chew Tablets 65
Oclacitinib Maleate 55
Carprofen 51
Spinosad 43
Sarolaner 39
Bedinvetmab 38
Fluralaner 13.64% 12-Week Chew 32
Maropitant Citrate 30
Trilostane 27
Outcome Breakdown
Outcome Unknown
476 (34.5%)
Recovered/Normal
427 (30.9%)
Ongoing
381 (27.6%)
Recovered with Sequela
38 (2.8%)
Euthanized
33 (2.4%)
Died
25 (1.8%)
Gender Distribution
Male 743 (50.6%)
Female 704 (48.0%)
Unknown 17 (1.2%)
Mixed 4 (0.3%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 43 | |
| 2011 | 56 | |
| 2012 | 67 | |
| 2013 | 67 | |
| 2014 | 89 | |
| 2015 | 102 | |
| 2016 | 108 | |
| 2017 | 112 | |
| 2018 | 122 | |
| 2019 | 108 | |
| 2020 | 116 | |
| 2021 | 85 | |
| 2022 | 82 | |
| 2023 | 102 | |
| 2024 | 130 | |
| 2025 | 79 | |
Pointing Dog - Hungarian Short-haired (Vizsla) Pet Health Insights
Pointing Dog - Hungarian Short-haired (Vizsla) accounts for 1,468 FDA adverse event reports, ranking #89 by volume among dog breeds, with 58 reports (4.0%) coded as a death outcome. Mean age at report: 4.7 years, average weight 23.0 kg (50.7 lbs).
Top reported signs: Vomiting (290), Lack of efficacy (endoparasite) - hookworm (119), Diarrhoea (110). Most-referenced drug: Milbemycin Oxime + Spinosad (237 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (207) and Afoxolaner (118).
Outcome coding on 1,380 status-recorded reports is dominated by Outcome Unknown (34.5%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Dog Breeds With a Similar Report Volume
Terrier - Scottish
1,461 reports · 5.8% death rate
Pointer (unspecified)
1,533 reports · 2.7% death rate
Corgi - Welsh Pembroke
1,555 reports · 4.2% death rate
American Pit Bull Terrier
1,326 reports · 6.9% death rate
Dalmatian
1,321 reports · 4.6% death rate
Terrier - Irish Soft-coated Wheaten
1,617 reports · 3.2% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Pointing Dog - Hungarian Short-haired (Vizsla)? ▼
There are 1,468 adverse event reports involving Pointing Dog - Hungarian Short-haired (Vizsla) in the FDA database, with 58 reports involving death (4.0% death rate). Pointing Dog - Hungarian Short-haired (Vizsla) ranks #89 by report volume.
What are the most common adverse reactions reported for Pointing Dog - Hungarian Short-haired (Vizsla)? ▼
The most commonly reported adverse reactions for Pointing Dog - Hungarian Short-haired (Vizsla) are Vomiting (290 reports), Lack of efficacy (endoparasite) - hookworm (119 reports), Diarrhoea (110 reports), Lethargy (see also Central nervous system depression in 'Neurological') (99 reports), Emesis (87 reports).
What drugs are most frequently associated with Pointing Dog - Hungarian Short-haired (Vizsla) adverse events? ▼
The drugs most frequently referenced in Pointing Dog - Hungarian Short-haired (Vizsla) adverse event reports are Milbemycin Oxime + Spinosad (237 reports), Ivermectin + Pyrantel As Pamoate Salt (207 reports), Afoxolaner (118 reports), Pyrantel Pamoate;Sarolaner (92 reports), Milbemycin Oxime + Praziquantel (81 reports).
What is the average age of Pointing Dog - Hungarian Short-haired (Vizsla) in adverse event reports? ▼
The average age of Pointing Dog - Hungarian Short-haired (Vizsla) at the time of adverse event reports is 4.7 years, with an average weight of 23.0 kg (50.7 lbs).
Does a high number of adverse event reports mean Pointing Dog - Hungarian Short-haired (Vizsla) is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Pointing Dog - Hungarian Short-haired (Vizsla) safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.